progscrape: psilocybin

Nearly 4 out of 5 Canadians believe that the use of psilocybin, the active ingredient in hallucinogenic mushrooms, is an acceptable medical approach to treat existential distress in patients suffering from a serious and incurable disease

2 years ago journals.sagepub.com disease health psilocybin

Psilocybin, a compound found in psychedelic “magic mushrooms,” significantly alters brain connectivity in rats

2 years ago psypost.org brain neuroscience psilocybin

New study reveals promising effects of psilocybin in treating severe depression in bipolar II disorder patients

2 years ago psypost.org medicine psilocybin

Oregon launches legal psilocybin access to the public

2 years ago cbsnews.com psilocybin

Scientists developed new compounds derived from psilocybin, the active ingredient in “magic mushrooms”, that are designed to reduce the psychedelic effects associated with psilocybin while maintaining its therapeutic benefits.

2 years ago pubs.acs.org chemistry psilocybin

Amanita Muscaria vs. Psychedelic Mushrooms (Psilocybin): What's the Difference?

2 years ago acslab.com psilocybin

Single-Dose Psilocybin for Major Depressive Disorder: Randomized Clinical Trial

2 years ago jamanetwork.com psilocybin trial

Psychedelic psilocybin-assisted therapy reduces depressive symptoms in adults with cancer and depression

2 years ago eurekalert.org cancer medicine

Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder was safe and feasible

2 years ago acsjournals.onlinelibrary.wiley.com cancer neuroscience

Psilocybin analog leads to 79% of remission in mid-stage depression trial

2 years ago drugdiscoverytrends.com medicine psilocybin trial